Wall Street analysts expect Dow Inc. (DOW) to post quarterly loss of $0.02 per share in its upcoming report, which indicates a year-over-year decline of 103.6%. Revenues are expected to be $10.27 billion, down 4.6% from the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 46% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a compan ...

Economic Performance - The Dow Jones Index is experiencing a significant decline, down 600 points, primarily due to disappointing Q1 earnings from UnitedHealthcare [1] - The S&P 500 and Nasdaq are performing positively, up 25 points and 140 points respectively, while the Dow has dropped 7.65% since April 2nd [2] Job Market - Weekly Jobless Claims remain low at 215K, which is 10K below expectations and 9K lower than the previous week's revised figure [3] - Continuing Claims increased slightly to 1.895 million, up from a revised 1.844 million, indicating stability in the job market [4] Housing Market - Housing Starts for March were reported at 1.324 million units, below the expected 1.41 million, marking the lowest level since November [5] - Building Permits showed a positive trend at 1.482 million units, exceeding expectations and indicating potential future growth in housing starts [6] Manufacturing Sector - The Philly Fed Index reported a significant decline to -26.4, the lowest level in two years, indicating a downturn in regional manufacturing [7] Company Earnings - UnitedHealthcare reported Q1 earnings of $7.20 per share, missing expectations by 7 cents, with revenues of $109.58 billion, down 1.4% from estimates [8] - American Express posted mixed Q1 results with earnings of $3.64 per share, exceeding expectations, while revenues of $16.97 billion fell short [9] - D.R. Horton reported Q2 earnings of $2.58 per share, missing estimates, and revenues of $7.73 billion, also below expectations, leading to a revenue forecast cut [10] - Netflix is expected to report earnings growth of 7.8% and revenue growth of 12.5% after the market close, having performed well year to date [11]

Wall Street plunged on Thursday on the final trading day of the week, with focus on US-Japan tariff talks, while a slump in UnitedHealth’s shares following a forecast cut by the insurer weighed on the Dow.In morning trading, the Dow Jones Industrial Average slid 637 points, or 1.6%, to 39,032. The S&P 500 fell 0.1%, and the Nasdaq was down 0.5%. 3 The Dow tumbled more than 600 points, or 1.6% on Thursday. Getty ImagesAhead of the long weekend, all three major Wall Street indexes are on track for weekly lo ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

Core Viewpoint - Procter & Gamble (P&G) is positioned as a resilient investment option amid trade tensions, with a strong history of dividend increases and a diversified product portfolio [1][2]. Company Overview - P&G operates in approximately 70 countries and sells products in about 180 countries, with higher international sales than domestic sales [3]. - The company has a complex supply chain, featuring 24 U.S. manufacturing sites and 78 international manufacturing sites [3]. Competitive Advantages - P&G's size and leadership across multiple product categories provide significant advantages, making it one of the largest global players in personal and household products [4]. - The company's diversification across brands and categories allows it to manage costs effectively and pass on higher costs to consumers when necessary [5]. Pricing Power and Sales Growth - Despite facing inflationary pressures and currency fluctuations, P&G has achieved net sales growth through price increases [6][7]. - The company’s pricing power is attributed to its competitive advantages in size and product variety, which enhance its negotiating leverage with suppliers [8]. Financial Performance - P&G's net sales growth over the last three fiscal years shows resilience despite challenges: - Fiscal 2022: 5% growth (2% volume, -2% foreign exchange, 4% price, 1% mix) - Fiscal 2023: 2% growth (-3% volume, -5% foreign exchange, 9% price, 1% mix) - Fiscal 2024: 2% growth (0% volume, -2% foreign exchange, 4% price, 0% mix) [8]. Valuation Concerns - P&G's current price-to-earnings (P/E) ratio is 26.6, above its 10-year median of 25.7, indicating a premium valuation relative to historical averages [11]. - The company may face negative earnings growth in the upcoming fiscal year if tariffs persist, raising concerns about its valuation [11]. Investment Considerations - P&G is considered a foundational dividend stock, with a 2.5% yield that is higher than the S&P 500 average of 1.4% [13]. - Despite its high valuation, P&G is viewed as a reliable investment for risk-averse investors due to its competitive advantages and ability to manage tariff-related costs [12][13].

Bank of America Securities analyst Steve Byrne downgraded Dow Inc. DOW to Underperform from Buy, lowering the price forecast from $44 to $28.The analyst cited a combination of weakening macroeconomic conditions, rising U.S. feedstock costs, and increasing trade barriers as factors creating a “perfect storm” for the company.As a result, Byrne has significantly reduced EBITDA forecasts for 2025 and 2026 by 17% and 23%, respectively. He now expects $4.8 billion and $5.4 billion.The company’s current valuation ...

Dow Inc (NYSE:DOW) stock is under pressure this morning, down 4.6% at $27.56 before the bell following a rare double downgrade from Bank of America. The firm slashed its rating on the chemical stock to "underperform" from "buy", citing a “perfect storm” of headwinds -- from a softening global economy to rising trade barriers. Alongside the downgrade, the analyst set a price target of $28.DOW managed a 0.8% gain last week, for its first weekly win in the last six, but the longer-term picture remains bleak. S ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

March 2025 might seem like ages ago in market years, as the Trump tariffs have rocked the market like few things before it. However, the trends in March are not so different from what's happening now, as consumer sentiment was rapidly weakening and fears of a recession were mounting before the tariff announcement.Let's take a look at the two best-performing Dow Jones Industrial Average (^DJI 1.26%) companies to see if they're worth buying today. 1. UnitedHealth Group (up 10.3% in March)UnitedHealth Group (U ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...